Research programme: anti-fungals - Agrivir
Latest Information Update: 22 Sep 2006
At a glance
- Originator Agrivir
- Developer Agrivir; BioAgri; Medivir AB
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 31 Dec 2005 Discontinued - Preclinical for Mycoses in Sweden (unspecified route)
- 23 Oct 2001 New profile
- 23 Oct 2001 Preclinical development for Mycoses in Sweden (Unknown route)